Abstract:
A pluggable mechanism, disposed between a bearing board and a to-be-inserted board, includes: a gear wrench hinged on the bearing board, where the gear wrench comprises a handle and a drive tooth part; and a swing gear, hinged on the bearing board and connected to the to-be-inserted board, where the swing gear comprises a gearing tooth part meshing with the drive tooth part, and the to-be-inserted board moves with the move of the swing gear. A production board including the above pluggable mechanism is also disclosed. A subrack including the above production board is also disclosed. The pluggable mechanism has a simple structure, high reliability, good operability, no occupation of vertical space, and small motion resistance, and is suitable for board plugging requiring great force for inserting and removing.
Abstract:
The present invention relates to (1- or 2- and/or 5 and/or 7-substituted)-(3-oxy)-(4H, 4-imino, 4-thioxo or 4-oxo)-pyrazolo[3,4-d]pyrimidin-6-ones, e.g., a compound of formula II as described below, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them. Of particular interest are novel compounds useful as inhibitors of phosphodiesterase 1 (PDE1), e.g., in the treatment of diseases involving disorders of the dopamine D1 receptor intracellular pathway, such as Parkinson's disease, depression, narcolepsy, damage to cognitive function, e.g., in schizophrenia, or disorders that may be ameliorated through enhanced progesterone-signaling pathway, e.g., female sexual dysfunction.
Abstract:
The present invention relates to optionally substituted (5- or 7-oxy)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(3H,6H)-ones, e.g., Compounds of Formula II-A′ or II-B′ as described herein, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Abstract:
An optical switch includes: a semiconductor substrate, including a first rotation part and a first torsion beam disposed at two ends of the first rotation part, where the first torsion beam is configured to drive the first rotation part to rotate; a microreflector, disposed on a surface of the first rotation part of the semiconductor substrate; a first latching structure, disposed on a surface of the first torsion beam, the first latching structure including a form self remolding (FSR) material layer and a thermal field source, where the thermal field source is configured to provide a thermal field for the FSR material layer and the FSR material layer is configured to undergo form remolding under the thermal field, so as to latch the first rotation part and the microreflector in a position after rotation.
Abstract:
Optionally substituted 3-(thio, sulfonyl or sulfonyl)-7,8-dihydro-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or a substituted 3-(thio, sulfinyl or sulfonyl)-7,8,9-trihydro-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Abstract:
The present invention relates to a health massage apparatus, providing a neck massager including a U-shaped neck pillow capable of being hungon a neck of a person, an inside of the U-shaped neck pillow corresponding to the neck has at least one massage component, the at least one massage component include at least two massage heads from the top down along the inside of the U-shaped neck pillow, a height of the upper massage head is lower than the adjacent lower massage head in sequence. According to the human neck characteristics involving the protrusion of the upper neck and the depression of the lower neck, in the present invention the upper massage head is set a low position and the lower massage head is set at a high position, advantageously, each of the massage heads respectively massages the corresponding neck part, the good massage effect can be obtained.
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Abstract:
The present invention relates to a cyclisation process of forming a multiple ring compound from an isoprenoid compound. The cyclisation process involves reacting the isoprenoid compound with an acetal initiator under conditions sufficient to form the multiple ring compound. The isoprenoid compound is contacted with an initiator and optionally with a catalyst. Cyclisation occurs by reaction of the initiator with the isoprenoid compound. Cyclic aceta compounds wherein the acetal forms part of 6-membered unsaturated ring are also defined.
Abstract:
Computing devices can autoconnect to access points even if they have not previously received authentication information for those access points. A computing device broadcasts a probe request, comprising a request for authentication information. An access point receiving such a probe request generates a probe response that provides authentication information that the computing device can then utilize to establish a useful communication connection to the access point. The provided authentication information can be either encrypted or unencrypted, and can be encrypted for specific users or specific computing devices. Dedicated application programs can decrypt encrypted authentication information, thereby enabling autoconnecting, while also delivering targeted information to users of the autoconnecting computing devices from a retailer hosting the access point. Authentication information for a “landing page” can be provided to a web browser to enable autoconnection.
Abstract:
A card connector (100) comprises an insulative housing (1), a plurality of contacts (2) retained in the insulative housing (1) and an ejecting mechanism (4). The insulative housing (1) defines an interface (14) in front and a receiving space (10) extending backwardly from the interface (14). The ejecting mechanism (4) comprises a slider (41), a spring (42) sandwiched between the slider (41) and the insulative housing (1), and a pole (43) for controlling the slider (41). The slider (41) defines a heart-shape groove (414) and a heart-shape block (415) located in the heart-shape groove (414). The heart-shape groove (414) includes a first slot (4141). The heart-shape block (415) includes a mucro (4154) at a rear end thereof. The mucro (4154) and the first slot (4141) define an escaping space (4153) therebetween. When the pole (43) moves aslant, the escaping space (4153) will receive the pole (43) for avoiding the pole (43) colliding with the mucro (4153).